Opinion|Videos|July 11, 2024
Factors Influencing Choice of Second-Generation BTKi Monotherapy
Specialists discuss factors influencing the choices of second-generation BTK monotherapy.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- When considering monotherapy with second-generation BTKi, what factors do you consider when choosing between available agents?
Advertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Aligning financial incentives with patient-centered care is becoming an increasingly complex path to navigate within oncology.
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
FDA Approves First Heart Valve to Keep Pace With Children's Growth
3
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
4
Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending
5